FDMT
USD4D Molecular Therapeutics Inc. Common Stock
Precio en Tiempo Real
Gráfico de Precios
Métricas Clave
Métricas de Mercado
Apertura
$11.020
Máximo
$11.020
Mínimo
$10.040
Volumen
0.63M
Fundamentos de la Empresa
Capitalización de Mercado
578.4M
Industria
Biotecnología
País
United States
Estadísticas de Negociación
Volumen Promedio
0.80M
Bolsa
NMS
Moneda
USD
Rango de 52 Semanas
Noticias Relacionadas
4DMT Announces Exclusive License Agreement with Otsuka Pharmaceutical Co., Ltd. for Development and Commercialization of 4D-150 in Asia-Pacific
4DMT to receive $85 million upfront cash payment and expect to receive at least $50 million of cost sharing from Otsuka over the next three years for development activities supporting global registration Up to $336
RBC Capital Reiterates Outperform on 4D Molecular Therapeutics, Maintains $26 Price Target
RBC Capital analyst Lisa Walter reiterates 4D Molecular Therapeutics with a Outperform and maintains $26 price target.
4DMT to Participate in Chardan's 9th Annual Genetic Medicines Conference
EMERYVILLE, Calif., Oct. 14, 2025 (GLOBE NEWSWIRE) -- 4D Molecular Therapeutics (NASDAQ:FDMT, 4DMT or the Company)), a leading late-stage biotechnology company advancing durable and disease-targeted therapeutics with
Acciones Relacionadas
Mantente Actualizado
Configura alertas de precio, recibe actualizaciones de análisis de IA y noticias de mercado en tiempo real.